Insulet Corp.
PODD
Classement en actions
#2093
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Prix de l'action
$141.47
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$9.81B
Changement (1 jour)
0.26%
Changement (1 an)
-56.72%
Pays
US
Échange Insulet Corp. (PODD)
Catégorie
Healthcare
Bénéfices pour Insulet Corp. (PODD)
Bénéfices en Jun 2026 TTM : $494.70M
Selon les derniers rapports financiers de Insulet Corp., les bénéfices actuels de l'entreprise sont de $494.70M. En 2023, l'entreprise a réalisé un bénéfice de $214.60M, une augmentation par rapport à celui de 2022 qui était de $9.80M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Insulet Corp. de 2002 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $494.70M | 64.79% |
| 2024 | $300.20M | 39.89% |
| 2023 | $214.60M | 2,089.80% |
| 2022 | $9.80M | -52.20% |
| 2021 | $20.50M | 111.34% |
| 2020 | $9.70M | -33.10% |
| 2019 | $14.50M | 178.85% |
| 2018 | $5.20M | -119.55% |
| 2017 | $-26.60M | -0.81% |
| 2016 | $-26.82M | -56.32% |
| 2015 | $-61.39M | 28.22% |
| 2014 | $-47.88M | 6.70% |
| 2013 | $-44.87M | -13.13% |
| 2012 | $-51.66M | -9.45% |
| 2011 | $-57.04M | -6.73% |
| 2010 | $-61.16M | -15.46% |
| 2009 | $-72.34M | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $7.51B | 1,418.29% |
US
|
|
| $5.56B | 1,024.52% |
IE
|
|
| $5.15B | 940.63% |
US
|
|
| $3.86B | 680.47% |
US
|
|
| - | - |
DE
|
